Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis
- 16 January 2018
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 169 (1) , 83-92
Abstract
Therapeutic exploitation of angiogenesis in breast cancer has been limited by the lack of reliable biomarkers. Circulating small-sized endothelial microparticles (sEMP) are likely to play a significant role as messengers of angiogenesis. Higher levels of EMP have been observed in cancer patients, but their prognostic value in breast cancer is unknown. Our aim was to determine the value of circulating sEMP as a marker of response to chemotherapy in breast cancer.Keywords
Funding Information
- FP7 People: Marie-Curie Actions (Grant 608765)
- Calasparra se mueve
This publication has 32 references indexed in Scilit:
- Levels of Circulating Microparticles in Lung Cancer Patients and Possible Prognostic ValueDisease Markers, 2013
- Microparticles in AngiogenesisCirculation Research, 2011
- Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolismThrombosis Research, 2011
- Microparticles – messengers of biological informationJournal of Cellular and Molecular Medicine, 2010
- Flow cytometric analysis of circulating microparticles in plasmaCytometry Part A, 2010
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancerHuman Pathology, 2008
- Chemotherapy‐induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activityJournal of Thrombosis and Haemostasis, 2007
- REporting recommendations for tumor MARKer prognostic studies (REMARK)Breast Cancer Research and Treatment, 2006
- Shedding of the Matrix Metalloproteinases MMP-2, MMP-9, and MT1-MMP as Membrane Vesicle-Associated Components by Endothelial CellsThe American Journal of Pathology, 2002